Your browser doesn't support javascript.
loading
Spike-antibody waning after second dose of BNT162b2 or ChAdOx1.
Shrotri, Madhumita; Navaratnam, Annalan M D; Nguyen, Vincent; Byrne, Thomas; Geismar, Cyril; Fragaszy, Ellen; Beale, Sarah; Fong, Wing Lam Erica; Patel, Parth; Kovar, Jana; Hayward, Andrew C; Aldridge, Robert W.
Afiliación
  • Shrotri M; Institute of Health Informatics, University College London, WC1E 6BT London, UK.
  • Navaratnam AMD; Institute of Health Informatics, University College London, WC1E 6BT London, UK.
  • Nguyen V; Institute of Health Informatics, University College London, WC1E 6BT London, UK.
  • Byrne T; Institute of Health Informatics, University College London, WC1E 6BT London, UK.
  • Geismar C; Institute of Health Informatics, University College London, WC1E 6BT London, UK.
  • Fragaszy E; Institute of Health Informatics, University College London, WC1E 6BT London, UK.
  • Beale S; Institute of Health Informatics, University College London, WC1E 6BT London, UK.
  • Fong WLE; Institute of Health Informatics, University College London, WC1E 6BT London, UK.
  • Patel P; Institute of Health Informatics, University College London, WC1E 6BT London, UK.
  • Kovar J; Institute of Health Informatics, University College London, WC1E 6BT London, UK.
  • Hayward AC; Institute of Health Informatics, University College London, WC1E 6BT London, UK.
  • Aldridge RW; Institute of Health Informatics, University College London, WC1E 6BT London, UK. Electronic address: r.aldridge@ucl.ac.uk.
Lancet ; 398(10298): 385-387, 2021 07 31.
Article en En | MEDLINE | ID: mdl-34274038

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glicoproteína de la Espiga del Coronavirus / Vacunas contra la COVID-19 / SARS-CoV-2 / Anticuerpos Antivirales Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glicoproteína de la Espiga del Coronavirus / Vacunas contra la COVID-19 / SARS-CoV-2 / Anticuerpos Antivirales Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido